Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Evaluation of HEMOBLAST™ Bellows Performance and Safety in Open Gynecological, Urological, ENT, Head and Neck, and Vascular Surgeries

NCT03873168 is registered in ClinicalTrials.gov with Biom'Up France SAS as lead sponsor.

NCT NCT03873168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03873168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Evaluation of HEMOBLAST™ Bellows Performance and Safety in Open Gynecological, Urological, ENT, Head and Neck, and Vascular Surgeries
Lead sponsor
Biom'Up France SAS
Phase
Observational
Overall status
Terminated
Start date
May 9, 2019
Completion date
July 27, 2021
Enrollment
64 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hemostasis